Medical advertising

ACE (Doxorubicin + Cyclophosphamide + Etoposide)

Used For:

Overview:

Administration and safety:
  • Inpatient schedule
  • Pretreatment cardiac assessment if clinically indicated or previous exposure to anthracyclines.
  • Risk of cardiomyopathy increases with total doxorubicin dose > 450 mg/m2.
  • Discontinue if cardiac failure occurs
  • Consider doxorubicin dose reduction if significant liver impairment

Constituents:


Article Tools:


E-mail E-mail Bookmark/Add to Favourites Print Print twitter Twitter facebook Facebook

Article Dates:

Created: 12/5/2006 Modified: 12/5/2006
Current Sponsors
Medical advertising
Current Sponsors
Sponsors Logos
Current Sponsors
Our site has been approved by the HealthInsite Editorial Board to be a HealthInsite information partner site PANDORA is a digital archive dedicated to the preservation of and long term access to Australian online electronic publications of national significance WAITTA Winner 2008 Online secretsFinalist priministeraward
Prime Minister's Award 		secretsFinalist
Current Sponsors

Virtual Medical Centre

Please be aware that we do not give advice on your individual medical condition,
if you want advice please see your treating physician.

Information on this site must be discussed with your treating doctor.

Virtual Medical Centre © 2002 - 2009 | Privacy Policy Last updated 21 Nov 2009

For Banner Advertising
MediaSmart

Website and videos by
Titan Interactive, Website and Web Design Perth Australia
^ Back to Top